A preliminary study on the immunogenicity in rabbits and in human volunteers of a recombinant vaccinia virus expressing Epstein-Barr virus membrane antigen.
Gu
S
S
Institute of Virology, Chinese Academy of Preventive Medical Sciences, Beijing.
Huang
T
T
Miao
Y
Y
Ruan
L
L
Zhao
Y
Y
Han
C
C
Xiao
Y
Y
Zhu
J
J
Wolf
H
H
D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis*; D000956:Antigens, Viral / Q000276:immunology*; D036022:Capsid Proteins; D002648:Child; D002675:Child, Preschool; D019309:Epstein-Barr Virus Nuclear Antigens; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007223:Infant; D008297:Male; D011817:Rabbits; D014412:Tumor Virus Infections / Q000517:prevention & control; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000276:immunology; D014763:Viral Matrix Proteins
D000914:Antibodies, Viral; D000956:Antigens, Viral; D036022:Capsid Proteins; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D019309:Epstein-Barr Virus Nuclear Antigens; C041788:Epstein-Barr viral capsid antigen; D014614:Vaccines, Synthetic; D014763:Viral Matrix Proteins